Quick Takeaways
- Mark S. Forman has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $56,272.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Mark S. Forman and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PASG | Passage BIO, Inc. | Chief Medical Officer | $56,272 | 15 Mar 2024 | ||
| VTYX | Ventyx Biosciences, Inc. | Chief Medical Officer | $0 | 04 Mar 2026 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|